Related references
Note: Only part of the references are listed.Knock-in of Mutated hTAU Causes Insulin Resistance, Inflammation and Proteostasis Disturbance in a Mouse Model of Frontotemporal Dementia
Claire Hull et al.
MOLECULAR NEUROBIOLOGY (2020)
Nonesterified fatty acids, cognitive decline, and dementia
Kenneth J. Mukamal
CURRENT OPINION IN LIPIDOLOGY (2020)
GluT4: A central player in hippocampal memory and brain insulin resistance
Ewan C. McNay et al.
EXPERIMENTAL NEUROLOGY (2020)
Increased levels of Aβ42 decrease the lifespan of ob/ob mice with dysregulation of microglia and astrocytes
Mitsuru Shinohara et al.
FASEB JOURNAL (2020)
FGF21 Protects against Aggravated Blood-Brain Barrier Disruption after Ischemic Focal Stroke in Diabetic db/db Male Mice via Cerebrovascular PPAR gamma Activation
Yinghua Jiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Liraglutide Protects Against Brain Amyloid-beta(1-42) Accumulation in Female Mice with Early Alzheimer's Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation
Ana I. Duarte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study
Francesco Vadini et al.
INTERNATIONAL JOURNAL OF OBESITY (2020)
Changes in Metabolic Syndrome Status and Risk of Dementia
Ji Eun Lee et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan
Kuan-Chan Chen et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study
Esra Ates Bulut et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2020)
Metabolic syndrome exacerbates amyloid pathology in a comorbid Alzheimer's mouse model
Alpna Tyagi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Brain insulin resistance: role in neurodegenerative disease and potential for targeting
Christian Holscher
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD
Cheng Li et al.
BRAIN AND BEHAVIOR (2020)
Brain insulin sensitivity is linked to adiposity and body fat distribution
Stephanie Kullmann et al.
NATURE COMMUNICATIONS (2020)
Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes
Carmen Hierro-Bujalance et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis
Jian-Bo Zhou et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
Antonella Tramutola et al.
NEUROBIOLOGY OF DISEASE (2020)
Structural and functional consequences in the amygdala of leptin-deficient mice
Jens Schepers et al.
CELL AND TISSUE RESEARCH (2020)
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia A Randomized Clinical Trial
Suzanne Craft et al.
JAMA NEUROLOGY (2020)
Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia
Timo Pekkala et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial
Tali Cukierman-Yaffe et al.
LANCET NEUROLOGY (2020)
Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study
Katherine Samaras et al.
DIABETES CARE (2020)
PPARγ-mediated microglial activation phenotype is involved in depressive-like behaviors and neuroinflammation in stressed C57BL/6J and ob/ob mice
Xiaqing Qin et al.
PSYCHONEUROENDOCRINOLOGY (2020)
The role of neutrophils in mediating stroke injury in the diabetic db/db mouse brain following hypoxia-ischemia
Rashmi Kumari et al.
NEUROCHEMISTRY INTERNATIONAL (2020)
Dysregulation of Insulin-Linked Metabolic Pathways in Alzheimer's Disease: Co-Factor Role of Apolipoprotein E ε4
James Robbins et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2020)
Alterations of Brain Energy Metabolism in Type 2 Diabetic Goto-Kakizaki Rats Measured In Vivo by 13C Magnetic Resonance Spectroscopy
Freya-Merret Girault et al.
NEUROTOXICITY RESEARCH (2019)
Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes
Gregory N. Ruegsegger et al.
FASEB JOURNAL (2019)
Risk of Incident Dementia According to Metabolic Health and Obesity Status in Late Life: A Population-Based Cohort Study
Ji-Yeon Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Intranasal insulin activates Akt2 signaling pathway in the hippocampus of wild-type but not in APP/PS1 Alzheimer model mice
Sami Gabbouj et al.
NEUROBIOLOGY OF AGING (2019)
Sitagliptin protects the cognition function of the Alzheimer's disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings
Qing Dong et al.
NEUROSCIENCE LETTERS (2019)
Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts
Galit Weinstein et al.
PLOS ONE (2019)
The Link Between Tau and Insulin Signaling: Implications for Alzheimer's Disease and Other Tauopathies
Rafaella Araujo Goncalves et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Distribution of insulin in trigeminal nerve and brain after intranasal administration
Jeffrey J. Lochhead et al.
SCIENTIFIC REPORTS (2019)
Impairment of cognitive flexibility in type 2 diabetic db/db mice
Leonid M. Yermakov et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Cell-specific expression of insulin/insulin-like growth factor-I receptor hybrids in the mouse brain
L. Martinez-Rachadell et al.
GROWTH HORMONE & IGF RESEARCH (2019)
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice
Yuriko Nakaoku et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Glycogen metabolism is impaired in the brain of male type 2 diabetic Goto-Kakizaki rats
Ana Francisca Soares et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2019)
Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies
Zhou Zhang et al.
DIABETES CARE (2019)
Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease
Maja Mustapic et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Chronic synaptic insulin resistance after traumatic brain injury abolishes insulin protection from amyloid beta and tau oligomer-induced synaptic dysfunction
Whitney Franklin et al.
SCIENTIFIC REPORTS (2019)
Effects of vildagliptin, a DPP-4 inhibitor, in elderly diabetic patients with mild cognitive impairment
Antonio Maria Borzi et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2019)
Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5 x FAD mouse model of Alzheimer's disease
Jingjing An et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial
Geert Jan Biessels et al.
DIABETES CARE (2019)
Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice
Chaitanya Chakravarthi Gali et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
Intranasal Targeting of Hypothalamic PTP1B and TCPTP Reinstates Leptin and Insulin Sensitivity and Promotes Weight Loss in Obesity
Garron T. Dodd et al.
CELL REPORTS (2019)
Neural correlates of liraglutide effects in persons at risk for Alzheimer's disease
Kathleen T. Watson et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Midlife Modifiable Risk Factors for Dementia: A Systematic Review and Meta-analysis of 34 Prospective Cohort Studies
Xiao-Ying Li et al.
CURRENT ALZHEIMER RESEARCH (2019)
Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies
Anna Rita Atti et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance
W. A. Banks et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain
Suresh Kumar Swaminathan et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
The insulin receptor is expressed and functional in cultured blood-brain barrier endothelial cells but does not mediate insulin entry from blood to brain
Maria Hersom et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease
Hong-Yan Cai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Thiazolidinediones as antidiabetic agents: A critical review
M. J. Nanjan et al.
BIOORGANIC CHEMISTRY (2018)
Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease
Jingjing Tai et al.
BRAIN RESEARCH (2018)
DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease
Yue Cao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease
Tian Li et al.
HIPPOCAMPUS (2018)
Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review
Konstantinos Ioannis Avgerinos et al.
JOURNAL OF NEUROLOGY (2018)
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
Andre F. Batista et al.
JOURNAL OF PATHOLOGY (2018)
Exenatide exerts cognitive effects by modulating the BDNF-TrkB neurotrophic axis in adult mice
Manuela Bomba et al.
NEUROBIOLOGY OF AGING (2018)
Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation
Laura L. Ekblad et al.
NEUROLOGY (2018)
Vildagliptin, a DPP4 inhibitor, alleviates diabetes-associated cognitive deficits by decreasing the levels of apoptosis-related proteins in the rat hippocampus
Dan-Dan Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Identification of Insulin Receptor Splice Variant B in Neurons by in situ Detection in Human Brain Samples
Brian Spencer et al.
SCIENTIFIC REPORTS (2018)
Insulin transport across the blood-brain barrier can occur independently of the insulin receptor
Elizabeth M. Rhea et al.
JOURNAL OF PHYSIOLOGY-LONDON (2018)
Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysis
Kingshuk Pal et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2018)
Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study
Nuria Mallorqui-Bague et al.
SCIENTIFIC REPORTS (2018)
Brain GLUT4 Knockout Mice Have Impaired Glucose Tolerance, Decreased Insulin Sensitivity, and Impaired Hypoglycemic Counterregulation
Candace M. Reno et al.
DIABETES (2017)
Insulin Regulates Astrocytic Glucose Handling Through Cooperation With IGF-I
Ana M. Fernandez et al.
DIABETES (2017)
Proteomic differences in brain vessels of Alzheimer's disease mice: Normalization by PPAR agonist pioglitazone
AmanPreet Badhwar et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease
Jayasankar Kosaraju et al.
MOLECULAR NEUROBIOLOGY (2017)
Tau hyperphosphorylation in the brain of ob/ob mice is due to hypothermia: Importance of thermoregulation in linking diabetes and Alzheimer's disease
Maud Gratuze et al.
NEUROBIOLOGY OF DISEASE (2017)
Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes
Na Zhao et al.
NEURON (2017)
Hyperglycemia induced the Alzheimer's proteins and promoted loss of synaptic proteins in advanced-age female Goto-Kakizaki (GK) rats
Hiranya Pintana et al.
NEUROSCIENCE LETTERS (2017)
Endothelial insulin receptors differentially control insulin signaling kinetics in peripheral tissues and brain of mice
Masahiro Konishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats
Piangkwan Sa-nguanmoo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degeneration
Lital Rachmany et al.
SCIENTIFIC REPORTS (2017)
Impact of Worsened Metabolic Syndrome on the Risk of Dementia: A Nationwide Cohort Study
Yen-Chun Fan et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer's disease
Ahmet Turan Isik et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Cognitive decline in type 2 diabetic db/db mice may be associated with brain region-specific metabolic disorders
Hong Zheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Unravelling the regulation of insulin transport across the brain endothelial cell
Sarah M. Gray et al.
DIABETOLOGIA (2017)
Metabolic Syndrome, Insulin Resistance, and Cognitive Dysfunction: Does Your Metabolic Profile Affect Your Brain?
Jesper S. Neergaard et al.
DIABETES (2017)
Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome
N. Hishikawa et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Linagliptin treatment improves cerebrovascular function and remodeling and restores reduced cerebral perfusion in Type 2 diabetes
Trevor Hardigan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)
The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice
Ping-Chia Li et al.
BMC NEUROSCIENCE (2016)
Glucagon-Like Peptide-1-Mediated Modulation of Inflammatory Pathways in the Diabetic Brain: Relevance to Alzheimer's Disease
LiMei Qin et al.
CURRENT ALZHEIMER RESEARCH (2016)
Increased risk of cognitive impairment in patients with components of metabolic syndrome
Chia-Kuang Tsai et al.
MEDICINE (2016)
Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease
Henrik H. Hansen et al.
PLOS ONE (2016)
Aβ-Induced Insulin Resistance and the Effects of Insulin on the Cholesterol Synthesis Pathway and Aβ Secretion in Neural Cells
Dema Najem et al.
NEUROSCIENCE BULLETIN (2016)
In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Michael Gejl et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing Aβ impairment of insulin signaling in an Alzheimer's disease mouse model
Elizabeth S. Chan et al.
SCIENTIFIC REPORTS (2016)
DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice
MingJie Ma et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Increased Oxidative Stress and Mitochondrial Dysfunction in Zucker Diabetic Rat Liver and Brain
Haider Raza et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline
V. A. Gault et al.
DIABETES OBESITY & METABOLISM (2015)
Dipeptidyl peptidase-4 inhibition in diabetic rats leads to activation of the transcription factor CREB in β-cells
Subbiah Pugazhenthi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats
Maha M. El Batsh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Sitagliptin attenuated brain damage and cognitive impairment in mice with chronic cerebral hypo-perfusion through suppressing oxidative stress and inflammatory reaction
Tzu-Hsien Tsai et al.
JOURNAL OF HYPERTENSION (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
Immune attack: the role of inflammation in Alzheimer disease
Frank L. Heppner et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's disease
Kai Lun Chang et al.
SCIENTIFIC REPORTS (2015)
Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain
Simon C. Cork et al.
MOLECULAR METABOLISM (2015)
Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia
Amy Claxton et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
DPP-4 Inhibitor and PPARγ Agonist Restore the Loss of CA1 Dendritic Spines in Obese Insulin-resistant Rats
Jirapas Sripetehwandee et al.
ARCHIVES OF MEDICAL RESEARCH (2014)
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
Bowen Lin et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice
Yanxing Chen et al.
EXPERIMENTAL NEUROLOGY (2014)
GABAergic Neurogliaform Cells Represent Local Sources of Insulin in the Cerebral Cortex
Gabor Molnar et al.
JOURNAL OF NEUROSCIENCE (2014)
Dipeptidyl Peptidase-4 Inhibitors Have Protective Effect on Cognitive Impairment in Aged Diabetic Patients With Mild Cognitive Impairment
Maria Rosaria Rizzo et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease
Paula L. McClean et al.
NEUROPHARMACOLOGY (2014)
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
Paula L. McClean et al.
NEUROPHARMACOLOGY (2014)
Lixisenatide improves recognition memory and exerts neuroprotective actions in high-fat fed mice
Rachael Lennox et al.
PEPTIDES (2014)
Rising Midlife Obesity Will Worsen Future Prevalence of Dementia
Binod Nepal et al.
PLOS ONE (2014)
Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and alzheimer's disease
Enrique Blazquez et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Amyloid-β Induces Hepatic Insulin Resistance In Vivo via JAK2
Yi Zhang et al.
DIABETES (2013)
DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption
Noppamas Pipatpiboon et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice
W. D. Porter et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
Pentamethylquercetin Protects Against Diabetes-Related Cognitive Deficits in Diabetic Goto-Kakizaki Rats
Xian-Hui Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats
Hiranya Pintana et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Astrogliosis in the brain of obese Zucker rat: A model of metabolic syndrome
Daniele Tomassoni et al.
NEUROSCIENCE LETTERS (2013)
Pioglitazone Improves Cognitive Function via Increasing Insulin Sensitivity and Strengthening Antioxidant Defense System in Fructose-Drinking Insulin Resistance Rats
Qing-Qing Yin et al.
PLOS ONE (2013)
Pioglitazone Improves Reversal Learning and Exerts Mixed Cerebrovascular Effects in a Mouse Model of Alzheimer's Disease with Combined Amyloid-beta and Cerebrovascular Pathology
Panayiota Papadopoulos et al.
PLOS ONE (2013)
Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats
Katharine Eakin et al.
PLOS ONE (2013)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin Production
Arya E. Mehran et al.
CELL METABOLISM (2012)
Amyloid-β Induces Hepatic Insulin Resistance by Activating JAK2/STAT3/SOCS-1 Signaling Pathway
Yi Zhang et al.
DIABETES (2012)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
PPAR gamma Agonist Improves Neuronal Insulin Receptor Function in Hippocampus and Brain Mitochondria Function in Rats with Insulin Resistance Induced by Long Term High-Fat Diets
Noppamas Pipatpiboon et al.
ENDOCRINOLOGY (2012)
Long-Term Pioglitazone Treatment Improves Learning and Attenuates Pathological Markers in a Mouse Model of Alzheimer's Disease
James L. Searcy et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Konrad Talbot et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Neuroprotective actions of Glucagon-like peptide-1 in differentiated human neuroprogenitor cells
Kalpana Velmurugan et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
Patrick Imfeld et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
Regulation of glucose transport by insulin: traffic control of GLUT4
Dara Leto et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Insulin in the brain: There and back again
William A. Banks et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status
Jennifer Rodriguez-Rivera et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb
Tomoko Kuwabara et al.
EMBO MOLECULAR MEDICINE (2011)
Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury
Andrew Sauerbeck et al.
EXPERIMENTAL NEUROLOGY (2011)
Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin
Chih-Cheng Hsu et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
Paula L. McClean et al.
JOURNAL OF NEUROSCIENCE (2011)
Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies
K. J. Anstey et al.
OBESITY REVIEWS (2011)
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer's Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
Michael Gold et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
Rosiglitazone and Cognitive Stability in Older Individuals With Type 2 Diabetes and Mild Cognitive Impairment
Angela M. Abbatecola et al.
DIABETES CARE (2010)
Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance
D. W. Porter et al.
DIABETES OBESITY & METABOLISM (2010)
Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet
V. A. Gault et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
GLP-1 Receptor Stimulation Reduces Amyloid-beta Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
Yazhou Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
Luis Escribano et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes
Shuko Takeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
Talib Abbas et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent
C. A. Grillo et al.
BRAIN RESEARCH (2009)
Overweight in midlife and risk of dementia: a 40-year follow-up study
L. B. Hassing et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans
Ethan J. Anderson et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Starvation and triglycerides reverse the obesity induced impairment of insulin transport at the blood-brain barrier
Akihiko Urayama et al.
ENDOCRINOLOGY (2008)
Rosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats
Asif R. Pathan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Amyloid beta oligomers induce impairment of neuronal insulin receptors
Wei-Qin Zhao et al.
FASEB JOURNAL (2008)
Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor γ agonist
Nektaria Nicolakakis et al.
JOURNAL OF NEUROSCIENCE (2008)
Central obesity and increased risk of dementia more than three decades later
R. A. Whitmer et al.
NEUROLOGY (2008)
Diabetic Goto-Kakizaki rats display pronounced hyperglycemia and longer-lasting cognitive impairments following ischemia induced by cortical compression
T. Moreira et al.
NEUROSCIENCE (2007)
Intranasal insulin improves memory in humans: Superiority of insulin aspart
Christian Benedict et al.
NEUROPSYCHOPHARMACOLOGY (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
M. E. Risner et al.
PHARMACOGENOMICS JOURNAL (2006)
Insulin regulates neuronal glucose uptake by promoting translocation of glucose transporter GLUT3
E Uemura et al.
EXPERIMENTAL NEUROLOGY (2006)
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone - A preliminary study
GS Watson et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2005)
Memory impairment in obese Zucker rats: An investigation of cognitive function in an animal model of insulin resistance and obesity
G Winocur et al.
BEHAVIORAL NEUROSCIENCE (2005)
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study
RA Whitmer et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Glucose transporter expression in the central nervous system: relationship to synaptic function
BS McEwen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Intranasal insulin improves memory in humans
C Benedict et al.
PSYCHONEUROENDOCRINOLOGY (2004)
Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-β exposure
PI Moreira et al.
DIABETES (2003)
Alzheimer's β-amyloid peptides compete for insulin binding to the insulin receptor -: art. no. RC221
L Xie et al.
JOURNAL OF NEUROSCIENCE (2002)
Brain and liver mitochondria isolated from diabetic Goto-Kakizaki rats show different susceptibility to induced oxidative stress
MS Santos et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2001)
Share Paper
